AQP9 can also mediate intracellular arsenic accumulation and arsenic hypersensitivity in leukemia cell line K562, human lung cancer cells, liver cancer cell line (HepG2) [15,16], and primary mouse hepatocytes [17]. This evidence concerns the gene AQP9 and liver cancer.